Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Bender

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Archives of Gynecology|January 1, 1985
[Complications of the efferent urinary tract in gynecologic operations]L Beck, J Bokelmann, H G Bender, et al.
Praxis|June 3, 1998
[Tumor risk consultation for predisposed women from high risk cancer families]M W Beckmann, D Niederacher, R Bodden-Heidrich, et al.
Anticancer Research|July 1, 1997
int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reactionH X An, D Niederacher, S I Dominik, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19A Schoenfeld, K H Kruger, J Gomm, et al.
International Journal of Cancer|October 20, 1995
ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissuesH X An, D Niederacher, M W Beckmann, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2005
The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsiaA Gerhardt, T W Goecke, M W Beckmann, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 21, 2005
Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancerM P Lux, S Ackermann, C Nestle-Krämling, et al.
British Journal of Cancer|May 1, 1996
Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancerM W Beckmann, F Picard, H X An, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Archives of Gynecology|January 1, 1985
[Complications of the efferent urinary tract in gynecologic operations]L Beck, J Bokelmann, H G Bender, et al.
Praxis|June 3, 1998
[Tumor risk consultation for predisposed women from high risk cancer families]M W Beckmann, D Niederacher, R Bodden-Heidrich, et al.
Anticancer Research|July 1, 1997
int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reactionH X An, D Niederacher, S I Dominik, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19A Schoenfeld, K H Kruger, J Gomm, et al.
International Journal of Cancer|October 20, 1995
ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissuesH X An, D Niederacher, M W Beckmann, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2005
The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsiaA Gerhardt, T W Goecke, M W Beckmann, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 21, 2005
Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancerM P Lux, S Ackermann, C Nestle-Krämling, et al.
British Journal of Cancer|May 1, 1996
Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancerM W Beckmann, F Picard, H X An, et al.
Pageof 15